GoodRx Holdings, Inc. (GDRX) Tops Q1 EPS by 2c, Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
GoodRx Holdings Inc. (GDRX) PT Lowered to $12 at Goldman Sachs
May 10, 2022 7:00 AM EDTGoldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $12.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "In its Q1 22 earnings report, GoodRx presented a solid quarterly report but framed the forward business trajectory as impacted by a "grocer" partner that had... More
